Inhibitory Receptors in Eosinophils of Atopic Subjects
NCT01489293 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2018-03-22
Summary
The purpose of this study is to analyze the expression and activity of inhibitory molecules on eosinophils obtained from allergic subjects.
Conditions
- Atopy
- Atopic Dermatitis
- Asthma
- Allergic Rhinitis
- Food Allergy
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Principal Investigators
-
Alon Y Hershko, MD, PhD · Meir Medical Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-05-01
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis
NCT00443495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
NCT02340130 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid
NCT00540631 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients
NCT04673591 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 ·Status: COMPLETED
-
House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
NCT01433523 ·Status: COMPLETED ·Phase: PHASE3
-
Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy
NCT01475188 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy
NCT00200850 ·Status: COMPLETED ·Phase: NA
-
Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites
NCT01052610 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
NCT00453583 ·Status: COMPLETED
-
Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
NCT00483353 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
NCT01160861 ·Status: COMPLETED ·Phase: PHASE1
-
Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects
NCT03039101 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract
NCT00927329 ·Status: WITHDRAWN ·Phase: PHASE1
-
Tolerability of SLIT With LAIS® Mites Allergoid Tablets
NCT02609581 ·Status: COMPLETED
-
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
NCT07348302 ·Status: RECRUITING ·Phase: PHASE3
-
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
NCT01608243 ·Status: COMPLETED ·Phase: PHASE1
-
The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis
NCT00119015 ·Status: TERMINATED ·Phase: PHASE4
-
The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
NCT01686048 ·Status: COMPLETED
-
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
NCT01318954 ·Status: COMPLETED
-
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
NCT01013116 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma
NCT06653322 ·Status: RECRUITING ·Phase: PHASE3